Allosteric Modulation of the Cannabinoid CB1 Receptor-Reference-Cited by-同舟云学术

Allosteric Modulation of the Cannabinoid CB1 Receptor

Published:2005-08-19 Issue:5 Volume:68 Page:1484-1495
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Price Martin R.,Baillie Gemma L.,Thomas Adèle,Stevenson Lesley A.,Easson Morag,Goodwin Richard,McLean Adèle,McIntosh Lorraine,Goodwin Gillian,Walker Glenn,Westwood Paul,Marrs Julia,Thomson Fiona,Cowley Phillip,Christopoulos Arthur,Pertwee Roger G.,Ross Ruth A.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference35 articles.

1. Targeting the endocannabinoid system in cancer therapy: A call for further research

2. Operational models of pharmacological agonism

3. Assessing the distribution of parameters in models of ligand–receptor interaction: to log or not to log

4. Christopoulos A (2000) Quantification of allosteric interactions at G protein-coupled Receptors using radioligand binding assays, in Current Protocols in Pharmacology (Enna SJ ed) pp 1.22.1-1.22.40. John Wiley & Sons, New York.

5. Allosteric binding sites on cell-surface receptors: novel targets for drug discovery

Cited by 392 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Negative allosteric modulation of CB1 cannabinoid receptor signaling suppresses opioid-mediated tolerance and withdrawal without blocking opioid antinociception;Neuropharmacology;2024-10

2. A universal cannabinoid CB1 and CB2 receptor TR-FRET kinetic ligand binding assay;2024-07-18

3. The CB1 negative allosteric modulator PSNCBAM-1 reduces ethanol self-administration via a nonspecific hypophagic effect;Pharmacology Biochemistry and Behavior;2024-07

4. Cannabinoid receptor 1 positive allosteric modulator ZCZ011 shows differential effects on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice;PLOS ONE;2024-06-24

5. Know your molecule: pharmacological characterization of drug candidates to enhance efficacy and reduce late-stage attrition;Nature Reviews Drug Discovery;2024-06-18